Skip to main content

Peer Review reports

From: Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer

Original Submission
24 Apr 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
18 May 2021 Reviewed Reviewer Report - Hans-christian Kolberg
1 Jun 2021 Reviewed Reviewer Report
21 Jun 2021 Author responded Author comments - FP Duhoux
Resubmission - Version 3
21 Jun 2021 Submitted Manuscript version 3
Publishing
30 Oct 2021 Editorially accepted
11 Nov 2021 Article published 10.1186/s12885-021-08950-x

You can find further information about peer review here.

Back to article page